Mohammad Valilo

524 total citations
29 papers, 345 citations indexed

About

Mohammad Valilo is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Mohammad Valilo has authored 29 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Nephrology. Recurrent topics in Mohammad Valilo's work include MicroRNA in disease regulation (7 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Circular RNAs in diseases (4 papers). Mohammad Valilo is often cited by papers focused on MicroRNA in disease regulation (7 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Circular RNAs in diseases (4 papers). Mohammad Valilo collaborates with scholars based in Iran, China and Türkiye. Mohammad Valilo's co-authors include Ashkan Kalantary‐Charvadeh, Mahmood Alizadeh Sani, Nasser Samadi, Hossein Safari, Ali Mota, Abbas Pirpour Tazehkand, Kobra Velaei, Yalda Yazdani, Iraj Alipourfard and Lei Xia and has published in prestigious journals such as Neuroscience Letters, The Journal of Membrane Biology and Biology of the Cell.

In The Last Decade

Mohammad Valilo

25 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Valilo Iran 11 188 77 61 34 29 29 345
Ashkan Kalantary‐Charvadeh Iran 10 158 0.8× 37 0.5× 52 0.9× 35 1.0× 36 1.2× 18 345
Mona A. Kortam Egypt 10 162 0.9× 93 1.2× 35 0.6× 68 2.0× 25 0.9× 12 355
Zhengang Tang China 8 163 0.9× 81 1.1× 30 0.5× 15 0.4× 32 1.1× 14 344
Rafael López‐Blanch Spain 10 230 1.2× 40 0.5× 95 1.6× 21 0.6× 43 1.5× 17 459
Lobna A. Saleh Egypt 9 119 0.6× 45 0.6× 23 0.4× 28 0.8× 22 0.8× 28 281
Shiming Zhang China 11 197 1.0× 41 0.5× 101 1.7× 28 0.8× 25 0.9× 30 431
Ruiyu Han China 9 145 0.8× 42 0.5× 37 0.6× 22 0.6× 27 0.9× 21 322
Rutong Ren China 12 194 1.0× 28 0.4× 72 1.2× 49 1.4× 19 0.7× 19 443
Dongfang Wu China 9 208 1.1× 75 1.0× 25 0.4× 38 1.1× 24 0.8× 16 365
Wen‐Fang Chen China 8 310 1.6× 50 0.6× 25 0.4× 25 0.7× 42 1.4× 8 456

Countries citing papers authored by Mohammad Valilo

Since Specialization
Citations

This map shows the geographic impact of Mohammad Valilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Valilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Valilo more than expected).

Fields of papers citing papers by Mohammad Valilo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Valilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Valilo. The network helps show where Mohammad Valilo may publish in the future.

Co-authorship network of co-authors of Mohammad Valilo

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Valilo. A scholar is included among the top collaborators of Mohammad Valilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Valilo. Mohammad Valilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valilo, Mohammad, et al.. (2025). Hormonal disorders in autism spectrum disorders. Hormone Molecular Biology and Clinical Investigation. 46(2). 57–66.
2.
3.
Maghsoudi, Hossein, et al.. (2025). The lncrnas: innovative multifunctional players of drug resistance in colorectal cancer. Cancer Cell International. 25(1). 442–442.
4.
Wang, Xiaomei, et al.. (2025). The crosstalk between Nrf2 and pyroptosis in diseases. Pathology - Research and Practice. 272. 156085–156085. 1 indexed citations
5.
Valilo, Mohammad, et al.. (2025). Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance. Medical Oncology. 42(4). 108–108. 9 indexed citations
6.
Bahadori, K., et al.. (2025). The crosstalk between exosomal miRNA and ferroptosis: A narrative review. Biology of the Cell. 117(1). e2400077–e2400077. 5 indexed citations
7.
Valilo, Mohammad, et al.. (2025). The Interaction between miRNAs and 14-3-3ζ Protein in Different Diseases. Protein and Peptide Letters. 32(6). 414–422. 1 indexed citations
8.
Valilo, Mohammad, et al.. (2024). Crosstalk between miRNAs and signaling pathways in the development of drug resistance in breast cancer. Hormone Molecular Biology and Clinical Investigation. 46(2). 47–55. 5 indexed citations
9.
Shakir, Maha, et al.. (2024). Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review. The Journal of Membrane Biology. 257(1-2). 3–16. 6 indexed citations
10.
Hemmati-Dinarvand, Mohsen, et al.. (2024). Correlation of PTEN signaling pathway and miRNA in breast cancer. Molecular Biology Reports. 51(1). 221–221. 11 indexed citations
11.
Yazdani, Yalda, et al.. (2023). NFR2/ABC transporter axis in drug resistance of breast cancer cells. Molecular Biology Reports. 50(6). 5407–5414. 19 indexed citations
12.
Valilo, Mohammad, et al.. (2023). Potential roles of the exosome/microRNA axis in breast cancer. Pathology - Research and Practice. 251. 154845–154845. 13 indexed citations
13.
Xia, Lei, et al.. (2023). The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer. Biochemia Medica. 33(3). 266–278. 21 indexed citations
14.
Yazdani, Yalda, et al.. (2023). Involvement of antioxidant enzymes in Parkinson’s disease. Pathology - Research and Practice. 249. 154757–154757. 14 indexed citations
15.
Alipourfard, Iraj, et al.. (2023). Role of the ER-induced UPR pathway, apoptosis, and autophagy in colorectal cancer. Pathology - Research and Practice. 248. 154706–154706. 14 indexed citations
16.
Valilo, Mohammad, et al.. (2022). The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy. Breast Cancer. 29(5). 778–789. 22 indexed citations
17.
Fakhri, Farima, et al.. (2022). Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson’s disease. Molecular Biology Reports. 49(11). 11061–11070. 10 indexed citations
18.
Hemmati-Dinarvand, Mohsen, et al.. (2021). Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran.. PubMed. 12(2). 155–161. 10 indexed citations
19.
Amiri, Fereshteh Talebpour, et al.. (2020). Dysregulation of body antioxidant content is related to initiation and progression of Parkinson’s disease. Neuroscience Letters. 736. 135297–135297. 11 indexed citations
20.
Valilo, Mohammad, et al.. (2019). Oxidative stress and Parkinson’s disease: conflict of oxidant-antioxidant systems. Neuroscience Letters. 709. 134296–134296. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashkan Kalantary‐Charvadeh Breakdown of academic impact, for papers by Mona A. Kortam Breakdown of academic impact, for papers by Zhengang Tang Breakdown of academic impact, for papers by Rafael López‐Blanch Breakdown of academic impact, for papers by Lobna A. Saleh Breakdown of academic impact, for papers by Shiming Zhang Breakdown of academic impact, for papers by Ruiyu Han Breakdown of academic impact, for papers by Rutong Ren Breakdown of academic impact, for papers by Dongfang Wu Breakdown of academic impact, for papers by Wen‐Fang Chen
Rankless by CCL
2026